I recently took a few months off from daily deadlines to explore the evolving world of biosimilars for the newest BioWorld Data report, The Biosimilars Game: A Scorecard for Opportunities, Threats and Critical Strategies. It was quite an eye-opening adventure.
Category Archives: emerging markets
A Stifled U.S. Biotech Sector: Is it Too Late to Recover?
June 20, 2012 – 4:37 pm
Join the Conversation